Rating
Buy
Price target
$135
Previous
$96
Implied upside
+26%

BofA Securities analyst Vivek Arya upgraded Intel (NASDAQ: INTC) from Underperform to Buy with a price target of $135.00 (from $96.00).

“We double-upgrade Intel (INTC) to Buy from Underperform on higher confidence in INTC’s opportunity to help address industry constraints in leading edge wafers/packaging, plus supply into a much larger agentic CPU TAM.

See accompanying industry report for INTC’s position in the rising server CPU opportunity of $170bn+ by CY30.

Overall, we now see the total IDM CY30 EPS power of $6+ vs. $3-4 prior, though execution in both product/foundry remains key.

We also point to the recent CDNS ‘14A node’ IP sign-up and Terafab engagements as additional supportive data points, helping build INTC’s longer-term visibility in external foundry with a more sustainable IP ecosystem.

We raise ests and PO to $135 from $96 prior, now based on a comprehensive IDM valuation of 25x at CY30E EPS power of ~$6.24, discounted back two years, given the longer-term nature of foundry opportunities and a shift from our prior CY28E sum-of-parts methodology.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.